<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2-5976-24
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2021
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Merional HG
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MENOTROPHIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        75
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        intramuscular, subcutaneous
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder and solvent for solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Restricted
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        69.00
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="IBSA INSTITUTE BIOCHIMIQUE S.A" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            IBSA INSTITUTE BIOCHIMIQUE S.A
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            IBSA INSTITUTE BIOCHIMIQUE S.A
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        G03GA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Merional HG is used to promote ovulation in<br />women who are not ovulating and who have not<br />responded to other treatment (clomiphene citrate).<br />Merional HG is used to bring about the<br />development of several follicles (and therefore<br />several eggs) in women receiving fertility<br />treatment.<br />Merional HG is a highly purifi ed human menopausal<br />gonadotrophin, belonging to a group of medicines<br />called gonadotrophins.<br />Each freeze-dried vial contains 75 IU human follicle<br />stimulating hormone activity (FSH) and 75 IU human<br />luteinising hormone activity (LH).<br />Human Chorionic Gonadotrophin (hCG), a hormone<br />naturally present in urine of pregnant women, is<br />added to contribute to the total LH activity.<br />Each freeze-dried vial contains 150 IU human follicle<br />stimulating hormone activity (FSH) and 150 IU human<br />luteinising hormone activity (LH).<br />Human Chorionic Gonadotrophin (hCG), a hormone<br />naturally present in urine of pregnant women, is<br />added to contribute to the total LH activity.<br />This medicinal product must be used under the<br />supervision of your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You and your partner&rsquo;s fertility will be evaluated<br />before your treatment is started.<br />Do not use Merional HG if you have any of the<br />following:<br />Enlarged ovaries or cysts not caused by a hormonal<br />disorder (polycystic ovarian disease).<br />Bleeding of unknown cause.<br />Cancer of the ovaries, uterus or breast.<br />Abnormal swelling (tumour) of the pituitary gland<br />or hypothalamus (brain).<br />Hypersensitivity (allergy) to Menotrophin or any of<br />the ingredients in Merional HG</p><p>This medicine should not be used if you have an early<br />menopause, a malformation of the sexual organs<br />or certain tumours of the womb that would make a<br />normal pregnancy impossible.<br />Warnings and Precautions<br />Although no allergic reactions to Merional HG have<br />yet been reported, you should tell your doctor if you<br />have an allergic reaction to similar medicines.<br />This treatment increases your risk of developing<br />a condition known as ovarian hyperstimulation<br />syndrome (OHSS) (see possible side effects). If<br />ovarian hyperstimulation occurs then your treatment<br />will be stopped and pregnancy will be avoided. The<br />fi rst signs of ovarian hyperstimulation are pain in the<br />lower abdominal region as well as nausea (feeling<br />sick), vomiting and weight gain. If these symptoms<br />occur you should be examined by your doctor as soon<br />as possible. In serious, but rare cases, the ovaries<br />can become enlarged and fl uid can build up in the<br />abdomen or chest.<br />The drug used to bring about the fi nal release<br />of mature eggs (containing human chorionic<br />gonadotrophin-hCG) can increase the likelihood of<br />OHSS. It is therefore not advisable to use hCG in<br />cases where OHSS is developing and you should not<br />have sexual intercourse even if using a barrier method<br />of contraception for at least 4 days.<br />It should be noted that women with fertility problems<br />have a higher rate of miscarriages than the normal<br />population.<br />In patients having treatment to help ovulation, the<br />occurrence of multiple pregnancies and births is<br />increased compared to natural conception. However,<br />this risk can be minimised by using the recommended<br />dose.<br />There is a slightly increased risk of extra-uterine<br />pregnancy (an ectopic pregnancy) in women with<br />damaged fallopian tubes.<br />Multiple pregnancies and characteristics of the<br />parents undergoing fertility treatments (e.g. maternal<br />age, sperm characteristics) may be associated with an<br />increased risk of birth defects.<br />Treatment with Merional HG, just as pregnancy<br />itself, may increase the chance of having thrombosis.<br />Thrombosis is the formation of a blood clot in a blood<br />vessel, most often in the veins of the legs or the lungs.<br />Please discuss this with your doctor, before starting<br />treatment, especially:<br />If you already know you have an increased chance<br />of having thrombosis.<br />If you, or anyone in your immediate family, have<br />ever had a thrombosis.<br />If you are severely overweight.</p><p>Paediatric population<br />The product is not intended for paediatric use.<br />Other medicines and Merional HG<br />Tell your doctor or pharmacist if you are taking<br />or have recently taken or might take any other<br />medicines.<br />Pregnancy, breast-feeding and fertility<br />Merional HG should not be used if you are pregnant<br />or breast-feeding.<br />Driving and using machines<br />Merional HG has no or negligible infl uence on the<br />ability to drive and use of machinery. However,<br />no studies on the effect on ability to drive and use<br />machines have been performed.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Dosage and duration of the treatment:<br />Always use this medicine exactly as your doctor has<br />told you. Check with your doctor if you are not sure.<br />Women who are not ovulating and are having<br />irregular periods or no periods at all:<br />As a general rule, the fi rst injection of one Merional<br />HG 75 IU vial is given during the fi rst week of the cycle<br />after spontaneous or induced menses.<br />Subsequently, Merional HG is injected daily at<br />the dosage prescribed by the physician and the<br />treatment will continue until one or more ripe follicle<br />have developed in the ovary. Your physician will<br />adjust the Merional HG dosage depending on the<br />ovarian response, which is determined by clinical<br />examinations.<br />As soon as one follicle reaches the required<br />development stage, the Merional HG treatment will<br />be withheld, and ovulation will be triggered with<br />another hormone (chorionic gonadotropin, hCG).<br />Ovulation generally takes place after 32 to 48 hours.<br />In this phase of the treatment, fertilization is possible.<br />You will be advised to have sexual intercourse every<br />day starting from the day preceding the administration<br />of hCG. If pregnancy is not achieved in spite of<br />ovulation, the treatment can be repeated.<br />Women undergoing ovarian stimulation for multiple<br />follicular development prior to in vitro fertilisation<br />or other assisted reproductive techniques:<br />The aim of this method is to obtain concomitant<br />multiple follicular development. The treatment will<br />start on the 2nd or 3rd day of the cycle with injections<br />of 150-300 IU of Merional HG (1-2 vials of Merional<br />HG 150 IU). Your physician may decide to administer<br />higher dosages if required. The injected dosage of<br />Merional HG is higher than in the method used for<br />natural fertilization. The continuation of the treatment<br />is adjusted individually by the physician.<br />As soon as a suffi cient number of follicles has<br />developed, the treatment with Merional HG is<br />withheld and ovulation is triggered by injecting<br />another hormone (chorionic gonadotropin, hCG).<br />How Merional HG should be given:<br />Merional HG is given by injection under your skin<br />(by the subcutaneous route) or into your muscle<br />(intramuscular injection).<br />Each vial should be used only once and the injection<br />should be used as soon as it is prepared.</p><p>After suitable advice and training your doctor may<br />ask you to inject Merional HG yourself.<br />For the fi rst time, your doctor must:<br />let you practise giving yourself a subcutaneous<br />injection,<br />have shown you the possible places where you<br />can inject yourself,<br />have shown you how to prepare the solution for<br />injection,<br />have explained how to prepare the right dose of<br />injection.<br />Before injecting Merional HG yourself, read the<br />following instructions carefully.<br />How to prepare and inject Merional HG using 1<br />vial of powder:<br />the solution must be prepared just before injection.<br />One vial is for single use only.<br />The medicinal product must be reconstituted under<br />aseptic conditions.<br />Merional HG must only be reconstituted with the<br />solvent provided in the package.<br />Prepare a clean surface and wash your hands before<br />the solution is reconstituted. It is important that your&nbsp;hands and the items you use are as clean as possible.<br />Set out all the following items on the clean surface:<br />two cotton wool alcohol swabs (not provided),<br />one vial containing Merional HG powder,<br />one solvent in ampoule,<br />one syringe (not provided),<br />one needle for preparing the injection (not<br />provided),<br />a fi ne bore needle for subcutaneous injection (not<br />provided).<br />Reconstitution of the solution for injection using 1<br />vial of powder<br />Prepare the solution for injection:<br />1.<br />The ampoule neck is specifi cally<br />designed to break more easily<br />below the coloured dot. Gently<br />fl ick the top of the ampoule to<br />dislodge any liquid remaining in<br />the tip. Hold the ampoule with<br />the coloured dot facing away from<br />you and snap off the top of the<br />ampoule as shown in the picture.<br />Using a cloth or ampoule-snapper<br />to hold the ampoule will help<br />protect your fi ngers.<br />Carefully place the opened<br />ampoule upright on the cleaned<br />surface.</p><p>Remove the protective cap of the needle.<br />Attach the reconstitution needle (large<br />needle) to the syringe.<br />With the syringe in one hand, pick up<br />the opened solvent ampoule, insert the<br />needle and draw up all the solvent into<br />the syringe.<br />Attach the protective cap of the needle.<br />Carefully set the syringe down on the<br />surface.<br />2.<br />Remove the coloured plastic cap (75 IU<br />light green, 150 IU dark green) from the<br />powder vial by gently pushing it upwards.<br />Disinfect the top of the rubber stopper<br />by wiping it with an alcohol swab and<br />allow to dry.<br />3.<br />Pick up the syringe, remove the needle<br />shield and slowly inject the solvent into<br />the powder vial through the middle of<br />the top of the rubber stopper.<br />Press the plunger down fi rmly to squirt all<br />the solution onto the powder.<br />DO NOT SHAKE, but gently roll the<br />vial between the hands until the powder<br />is completely dissolved, taking care to<br />avoid creating foam<br />4.<br />Once the powder is dissolved (which,<br />in general, occurs immediately), slowly<br />draw the solution into the syringe:<br />With the needle still inserted, turn the<br />vial upside down.<br />Make sure the needle tip is underneath<br />the level of the liquid.<br />Gently pull the plunger to draw all the<br />solution up into the syringe.<br />Check that the reconstitut</p><p>Preparation of higher doses, using more than 1 vial<br />of powder<br />If your doctor has recommended higher doses for<br />you, this can be achieved by using more than one vial<br />powder with one ampoule of solvent.<br />When reconstituting more than 1 vial of Merional HG<br />, at the end of step 4 above, draw the reconstituted<br />contents of the fi rst vial back into the syringe and<br />slowly inject into a second vial. Repeat steps 2 to<br />4 for the second and subsequent vials, and until the<br />contents of the required number of vials equivalent to<br />the prescribed dosage are dissolved (within the limit of<br />the maximum total dosage of 450 IU, corresponding<br />to a maximum of 6 vials of Merional HG 75 IU or 3<br />vials of Merional HG 150 IU).<br />Your doctor may increase your dose by 37.5 IU which<br />represents half a vial of Merional HG 75 IU.<br />For this you should reconstitute the contents of the 75<br />IU vial according to steps 2 to 3 described above and<br />draw half of this reconstituted solution (0.5 ml) back<br />into the syringe according to step 4.<br />In that situation you will have two preparations to be<br />injected: the fi rst preparation reconstituted in 1 ml<br />and the second containing 37.5 IU in 0.5 ml.<br />Both preparations will be injected with their own<br />syringe according to the following steps.<br />The solution must be clear and colourless.</p><p>Injecting your medicine subcutaneously:<br />When the syringe contains the<br />described dose, attach the protective<br />cap of the needle. Remove the needle<br />from the syringe and replace it with<br />the fi ne bore needle for subcutaneous<br />injection including its protective cap.<br />Push the fi ne bore needle fi rmly onto<br />the syringe barrel, then twist it slightly<br />to ensure it is fully screwed on and to<br />create a fi rm seal.<br />Remove the protective cap of the<br />needle. Hold the syringe with the<br />needle pointing upwards and gently<br />tap the side of the syringe to force any<br />air bubbles up to the top;<br />Push the plunger until a bead of liquid<br />appears at the tip of the needle.<br />Do not use if it contains any particles<br />or is cloudy.<br />The injection site:<br />Your doctor or nurse will have already advised you<br />where on your body to inject your medicine. The<br />usual places are the thigh or the lower abdominal<br />wall below the navel.<br />Wipe the injection site with an alcohol swab.</p><p>The injection site:<br />Your doctor or nurse will have already advised you<br />where on your body to inject your medicine. The<br />usual places are the thigh or the lower abdominal<br />wall below the navel.<br />Wipe the injection site with an alcohol swab.<br />Inserting the needle:<br />Firmly pinch the skin together. With<br />the other hand, insert the needle with<br />a dart-like motion at an angle of 45&deg;<br />or 90&deg;.<br />Injecting the solution:<br />Inject under the skin as you were shown. Do not<br />inject directly into a vein. Push the plunger slowly<br />and steadily, so the solution is correctly injected<br />and the skin tissues are not damaged.<br />Take as much time as you need to inject the volume of<br />solution prescribed. As described for the preparation<br />of the solution, depending on the dosage prescribed<br />by your doctor, you may not use the entire volume of<br />the solution.<br />Removing the needle:<br />Pull the syringe out quickly and apply pressure to the<br />injection site with a swab containing disinfectant. A&nbsp;gentle massage of the site &ndash; while still maintaining<br />pressure &ndash; helps disperse the Merional HG solution<br />and relieve any discomfort.</p><p>Injecting your medicine intramuscularly:<br />For intramuscular injections your healthcare provider<br />will prepare and then inject Merional HG into the<br />side of your thigh or buttock.<br />Dispose of all used items:<br />Once you have fi nished your injection, all the needles<br />and empty syringes should be disposed of in an<br />appropriate container. Any unused solution or waste<br />material should be disposed of in accordance with<br />local requirements.<br />If you use more Merional HG than you should:<br />The effects of an overdose of Merional HG are<br />unknown, nevertheless, one could expect ovarian<br />hyperstimulation syndrome to occur (see Possible<br />side effects). If you use more Merional HG than you<br />should, speak to your doctor or pharmacist.<br />If you forget to use Merional HG :<br />Take it at the next normal time for an injection. Do not<br />take double dose to make up for a forgotten dose.<br />If you stop using Merional HG :<br />Do not stop on your own initiative: Always consult your<br />doctor if you are considering stopping this medicine.<br />If you have any further questions on the use of this<br />medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Merional HG can cause side<br />effects, although not everybody gets them.<br />The following side effect is important and will require<br />immediate action if you experience it. You should<br />stop taking Merional HG and see your doctor<br />immediately if the following occurs:<br />Common, affects 1 to 10 users in 100:<br />Ovarian Hyperstimulation Syndrome (symptoms<br />include ovarian cyst formation or enlargement<br />of existing cysts, lower stomach pain, feeling<br />thirsty and sick, and sometimes being sick,<br />passing reduced quantities of concentrated urine<br />and weight gain) (see Section 2 for additional<br />information).<br />The following side-effects have also been reported:<br />Very Common (likely to affect up to 1 in 10 users):<br />Headache<br />Swollen or bloated stomach<br />Common (likely to affect between 1 in 100 and 1 in<br />10 users):<br />Abdominal pain or discomfort<br />Pelvic pain<br />Back pain<br />Sensation of heaviness<br />Breast discomfort<br />Dizziness<br />Hot fl ushes<br />Thirst<br />Feeling sick<br />Tiredness<br />Feeling generally unwell<br />Injection site reaction such as pain and infl ammation<br />(frequency higher with IM than SC).<br />Rare, (likely to affect between 1 in 10,000 and 1 in<br />1000 users):<br />Ovarian torsion (twisting of the ovary which causes<br />extreme pain in the lower abdomen)<br />Very rare, (likely to affect between 1 in 100,000 and 1<br />in 10,000 users):<br />Thromboembolism (formation of a clot in a blood</p><p>vessel that breaks loose and is carried by the blood<br />stream to block another vessel).<br />Reporting of side effects<br />If you get any side effects, talk to your doctor or<br />pharmacist. This includes any possible side effects<br />not listed in this leafl et.<br />You can also report side effects directly via [the<br />national reporting system &ndash; to be completed<br />nationally]. By reporting side effects you can help<br />provide more information on the safety of this<br />medicine.<br />To report any side effects:<br />&bull; Saudi Arabia:<br />The National Pharmacovigilance and Drug Safety<br />Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-<br />2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of<br />children.<br />Do not store above 25&deg; C. Keep the vial and the<br />ampoule of solvent in the outer carton in order to<br />protect from light.<br />Do not use this medicine after the expiry date which is<br />stated on the outer carton, the vial and the ampoule<br />of solvent. The expiry date refers to the last day of<br />the month.<br />Use immediately after reconstitution.<br />Do not use Merional HG if you notice the solution<br />does not look clear. After reconstitution the solution<br />must be clear and colourless.<br />Do not throw away any medicines via wastewater.<br />Ask your pharmacist how to throw away medicines<br />you no longer use. These measures will help protect<br />the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is menotrophin.<br />Each freeze-dried vial contains 75 IU human follicle<br />stimulating hormone activity (FSH) and 75 IU human<br />luteinising hormone activity (LH).<br />Human Chorionic Gonadotrophin (hCG), an hormone<br />naturally present in urine of pregnant women, is<br />added to contribute to the total LH activity.<br />Each freeze-dried vial contains 150 IU human follicle<br />stimulating hormone activity (FSH) and 150 IU human<br />luteinising hormone activity (LH).<br />Human Chorionic Gonadotrophin (hCG), an hormone<br />naturally present in urine of pregnant women, is<br />added to contribute to the total LH activity.<br />If multiple vials of powder are used, the amount of<br />menotrophin contained in 1 ml of reconstituted<br />solution will be as follows:</p><p>Merional HG 75 IU<br />powder and solvent for solution for injection<br />Number of<br />vials used<br />Total amount of menotrophin in 1<br />ml of solution<br />1 75 IU<br />2 150 IU<br />3 225 IU<br />4 300 IU<br />5 375 IU<br />6 450 IU<br />Merional HG 150 IU<br />powder and solvent for solution for injection<br />Number of<br />vials used<br />Total amount of menotrophin in<br />1 ml of solution<br />1 150 IU<br />2 300 IU<br />3 450 IU<br />The other excipients are<br />For the powder: lactose monohydrate.<br />For the solvent: sodium chloride and water for<br />injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Powder: white to almost white lyophilized powder
Solvent: clear and colourless solution.
Merional HG is presented as a powder and solvent
for solution for injection.
1 set contains the following:
One vial containing a white to almost white
powder
One ampoule (1 ml) containing a clear and
colourless solution
It comes in pack sizes of 1, 5 or 10 sets. Not all
pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>IBSA Institut Biochimique S.A.<br />Via al Ponte 13<br />6903 Lugano (Switzerland)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leafl et was last revised in December 2016
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p style="text-indent:50px">NA<br /></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            NA
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Merional HG 75 IU
Merional HG 150 IU
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ch freeze-dried vial contains 75 IU human follicle stimulating hormone activity (FSH) and
75 IU human luteinising hormone activity (LH).
Human Chorionic Gonadotrophin (hCG), a hormone naturally present in urine of pregnant
women, is added to contribute to the total LH activity.
Each freeze-dried vial contains 150 IU human follicle stimulating hormone activity (FSH)
and 150 IU human luteinising hormone activity (LH).
Human Chorionic Gonadotrophin (hCG), a hormone naturally present in urine of pregnant
women, is added to contribute to the total LH activity.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder and solvent for solution for injection.
Powder: white to almost white lyophilized powder
Solvent: clear and colourless solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ovulation induction: for the induction of ovulation in amenorrhoeic or anovulatory women<br />who have not responded to treatment with clomiphene citrate .<br />Controlled ovarian hyperstimulation (COH) within a medically assisted reproduction<br />technology (ART): induction of multiple follicular development in women undergoing<br />assisted reproduction techniques such as in vitro fertilization (IVF).<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Treatment with MERIONAL HG should be initiated under the supervision of a physician<br />experienced in the treatment of infertility problems.<br />There are great inter- and intra-individual variations in the response of the ovaries to<br />exogenous gonadotrophins. This makes it impossible to set a uniform dosage scheme. The<br />dosage should, therefore, be adjusted individually depending on the ovarian response. This<br />requires ultrasonography and may also include monitoring of oestradiol levels.<br />Females with anovulation:<br />The objective of a treatment with MERIONAL HG is to develop a single mature de Graaf<br />follicle from which the ovum will be released after the administration of human chorionic<br />gonadotrophin (hCG).<br />MERIONAL HG can be administered by daily injection. In menstruating patients the<br />treatment should begin within the first 7 days of the menstrual cycle.<br />A commonly used regimen starts at 75 to 150 IU of FSH per day and is increased if<br />necessary by 37.5 IU (up to 75 IU), with intervals of 7 or 14 days preferably, in order to<br />achieve an adequate but not excessive response.<br />Maximum daily dosages of HMG MERIONAL HG should generally not exceed 225 IU.<br />The treatment should be adjusted to the individual patient&#39;s response, assessed by measuring<br />the follicle size by ultrasonography and/or oestrogen levels.<br />The daily dose is then maintained until pre-ovulatory conditions are reached. Usually, 7 to 14<br />days of treatment is sufficient to reach this state.<br />The administration of MERIONAL HG is then discontinued and ovulation can be induced by<br />administering human chorionic gonadotrophin (hCG).</p><p>If the number of responding follicles is too high or oestradiol levels increase too rapidly, i.e.<br />more than a daily doubling for oestradiol for two or three consecutive days, the daily dose<br />should be decreased. Since follicles of over 14 mm may lead to pregnancies, multiple preovulatory<br />follicles exceeding 14 mm carry the risk of multiple gestations. In that case hCG<br />should be withheld and pregnancy should be avoided in order to prevent multiple gestations.<br />The patient should use a barrier method of contraception or refrain from having coitus until<br />the next menstrual bleeding has started (see section 4.4). The treatment should recommence<br />in the next treatment cycle at a lower dose than in the previous cycle.<br />If a patient fails to adequately respond after 4 weeks of treatment, the cycle should be<br />abandoned and the patient should recommence at a higher initial dose than in the previous<br />cycle.<br />Once the ideal response is obtained, a single injection of 5 000 IU to 10 000 IU of hCG<br />should be administered 24 to 48 hours after the last MERIONAL HG injection.<br />The patient is recommended to have coitus on the day of hCG injection and the following<br />day.</p><p>Alternatively, intrauterine insemination may be performed.</p><p>Females undergoing ovary stimulation for induction of multiple follicular development<br />&ndash; as part of assisted reproductive technology:<br />Pituitary down-regulation in order to suppress the endogenous LH peak and to control basal<br />levels of LH is now commonly achieved by administration of a gonadotrophin releasing<br />hormone agonist (GnRH agonist) or gonadotrophin releasing hormone antagonist (GnRHAntagonist).<br />In a commonly used protocol the administration of MERIONAL HG begins approximately<br />two weeks after the start of the agonist treatment, both treatments are then continued until<br />adequate follicular development has been achieved. For example, following two weeks of<br />pituitary down-regulation with agonist, 150 to 225 IU of MERIONAL HG are administered<br />for the first five-seven days. The dose is then adjusted according to the patient&#39;s ovarian<br />response.<br />An alternative protocol for controlled ovarian hyperstimulation involves the administration of<br />150 to 225 IU of MERIONAL HG daily starting on the 2nd or 3rd day of the cycle. The<br />treatment is continued until sufficient follicular development has been achieved (assessed by<br />monitoring of serum oestrogen concentrations and/or ultrasound) with the dose adjusted<br />according to the patient&#39;s response (usually not higher than 450 IU daily). Adequate follicular<br />development is usually achieved on average around the tenth day of treatment (5 to 20 days).<br />When an optimal response is obtained a single injection of 5 000 IU to 10 000 IU of hCG<br />administered 24 to 48 hours after the last MERIONAL HG injection, to induce final<br />follicular maturation.<br />Oocyte retrieval is performed 34-35 hours later.</p><p>Paediatric population<br />The product is not intended for paediatric use<br />Method of administration<br />MERIONAL HG is intended for subcutaneous and intramuscular administration.<br />The powder should be reconstituted immediately prior to use with the solvent provided.<br />To prevent painful injections and minimize leakage from the injection site MERIONAL HG<br />should be slowly administered subcutaneously. The subcutaneous injection site should be<br />alternated to prevent lipo-atrophy. Any unused solution should be discarded.<br />Subcutaneous injections can be self-administered by the patient, provided the physician&#39;s<br />instructions and recommendations are strictly followed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 Hypersensitivity to Menotrophin or to any of the excipients
 Ovarian enlargement or cysts not related to polycystic ovarian syndrome
 Gynaecological bleeding of unknown cause
 Ovarian, uterine or breast carcinoma
 Tumours of the hypothalamus or pituitary gland
MERIONAL HG is contraindicated when an effective response cannot be achieved, for
example:
 Primary ovarian failure
 Malformations of sexual organs incompatible with pregnancy
 Fibroid tumours of the uterus incompatible with pregnancy
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Anaphylactic reactions may occur, particularly in patients with known hypersensitivity to<br />gonadotropins. The first injection of MERIONAL HG should be always performed under<br />direct medical supervision and in settings with facilities for cardio-pulmonary resuscitation.<br />The first injection of MERIONAL HG should be performed under direct medical<br />supervision.<br />Self-injections of MERIONAL HG should be performed only by motivated, trained and well<br />informed patients. Prior to self-injections, the patient must be shown how to perform a<br />subcutaneous injection, showing her where the injection can be given and how to prepare the<br />solution to be injected.<br />Before starting the treatment, the couple&#39;s infertility should be assessed as appropriate and<br />putative contraindications for pregnancy evaluated. In particular, patients should be evaluated<br />for hypothyroidism, adrenocortical deficiency, hyperprolactinemia and pituitary or<br />hypothalamic tumours, for which appropriate specific treatments are given.<br />Ovarian hyperstimulation syndrome (OHSS)<br />Ultrasonographic assessment of follicular development, and determination of oestradiol<br />levels should be performed prior to treatment and monitored at regular intervals during<br />treatment. This is particularly important at the beginning of the stimulation (see below).<br />Apart from the development of a high number of follicles, oestradiol levels may rise very<br />rapidly, e.g. more than a daily doubling for two or three consecutive days, and possibly<br />reaching excessively high values. The diagnosis of ovarian hyperstimulation may be<br />confirmed by ultrasound examination. If this unwanted ovarian hyperstimulation occurs (i.e.<br />not as part of controlled ovarian hyperstimulation in medically assisted reproduction<br />programs), the administration of MERIONAL HG should be discontinued. In that case<br />pregnancy should be avoided and hCG must be withheld, because it may induce, in addition<br />to multiple ovulation, the ovarian hyperstimulation syndrome (OHSS). Clinical symptoms and<br />signs of mild ovarian hyperstimulation syndrome are abdominal pain, nausea, diarrhoea, and<br />mild to moderate enlargement of ovaries and ovarian cysts. In rare cases severe ovarian</p><p>hyperstimulation syndrome occurs, which may be life-threatening. This is characterised by<br />large ovarian cysts (prone to rupture), ascites, often hydrothorax and weight gain. In rare<br />instances, venous or arterial thromboembolism may occur in association with OHSS (see<br />section 4.8).<br />Multiple Pregnancies<br />In patients undergoing ART procedures the risk of multiple pregnancies is related mainly to<br />the number of replaced embryos. In patients undergoing a treatment for ovulation induction<br />the incidence of multiple pregnancies and births is increased as compared to natural<br />conception. The majority of multiple conceptions are twins. To minimise the risk of multiple<br />pregnancy, careful monitoring of ovarian response is recommended.<br />Pregnancy wastage<br />The incidence of spontaneous miscarriage is higher in patients treated with FSH than in the<br />general population, but it is comparable to the incidence found in women with other fertility<br />disorders.<br />Ectopic pregnancy<br />Since infertile women undergoing assisted reproduction, and particularly IVF, often have<br />tubal abnormalities the incidence of ectopic pregnancies might be increased. Early ultrasound<br />confirmation that a pregnancy is intrauterine is therefore important.<br />Reproductive system neoplasms<br />There have been reports of ovarian and other reproductive system neoplasms, both benign<br />and malignant, in women who have undergone multiple drug regimens for infertility<br />treatment. It is not yet established if treatment with gonadotropins increases the baseline risk<br />of these tumours in infertile women.<br />Congenital malformation<br />The prevalence of congenital malformations after ART may be slightly higher than after<br />spontaneous conceptions. This is thought to be due to differences in parental characteristics<br />(e.g. maternal age, sperm characteristics) and multiple pregnancies.<br />Thromboembolic events<br />Women with generally recognised risk factors for thromboembolic events, such as personal<br />or family history, severe obesity (Body Mass Index &gt; 30 kg/m2) or thrombophilia, may have<br />an increased risk of venous or arterial thromboembolic events, during or following treatment<br />with gonadotrophins. In these women, the benefits of gonadotrophin administration need to<br />be weighed against the risks (see section 4.8).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No drug/drug interaction studies have been conducted for MERIONAL HG in humans.<br />Although there is no clinical experience, it is expected that the concomitant use of<br />MERIONAL HG 75-150 IU and clomiphene citrate may enhance the follicular response.<br />When using GnRH agonist for pituitary desensitisation, a higher dose of MERIONAL HG<br />75-150 IU may be necessary to achieve adequate follicular response</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />MERIONAL HG should not be used during pregnancy &ldquo;Category X&rdquo;.<br />No teratogenic risk has been reported following controlled ovarian stimulation in clinical use<br />with urinary gonadotrophins. To date, no other relevant epidemiological data are available.<br />Animal studies do not indicate teratogenic effect.<br />Lactation<br />MERIONAL HG should not be used during lactation.<br />During lactation the secretion of prolactin can entail a poor response to ovarian stimulation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed.<br />However, MERIONAL HG is unlikely to have influence on the patient&rsquo;s performance to<br />drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most relevant occurring adverse drug reaction in clinical trials with MERIONAL HG is<br />(dose-related) ovarian hyperstimulation (OHSS), generally mild with small ovarian<br />enlargement, abdominal discomfort or pain. Only one case of OHSS was serious.<br />The most frequent adverse reactions with MERIONAL HG were headache and abdominal<br />distension as well as nausea, fatigue, dizziness and pain at the injection site<br />The table below displays the main adverse drug reactions (&gt;1%) in women treated with<br />MERIONAL HG in clinical trials according to body system and frequency. Within each<br />frequency grouping, adverse reactions are presented in order of decreasing seriousness.<br />Within each system organ class, the ADRs are ranked under headings of frequency, most<br />frequent reactions first, using the following convention:<br />Very common ( 1/10); common (1/100 to 1/10); uncommon (1/1,000 to 1/100); rare<br />(1/10,000 to 1/1,000); very rare (1/10,000), not known (cannot be estimated form the<br />available data).</p><p>From published studies, the following adverse reactions have been seen in patients treated<br />with human menopausal gonadotrophins.<br />*Severe ovarian hyperstimulation (OHSS) with marked ovarian enlargement and cyst<br />formation, acute abdominal pain, ascites, pleural effusion, hypovolaemia, shock and<br />thromboembolic disorders. (See also section 4.4)<br />* Ovarian torsion, usually in association with severe cases of OHSS<br />* Rupture of ovarian cysts with intraperitoneal haemorrhage, fatal outcomes of cyst rupture<br />have been reported.<br />*Allergic reactions also with generalised symptoms have been reported after treatment with<br />gonadotrophin containing products. (See also section 4.4)<br />Local reactions at the site of injection such as pain, redness, bruising, swelling and/or<br />irritation are expected AE following administration of gonadotrophins.<br />The frequency of such events are expected to be higher with the intramuscular than with the<br />subcutaneous administration.</p><p>Reporting of suspected adverse reactions<br />Reporting suspected adverse reactions after authorisation of the medicinal product is<br />important. It allows continued monitoring of the benefit/risk balance of the medicinal<br />product.</p><p>To report any side effects:<br /> Saudi Arabia:<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br /> Fax: +966-11-205-7662<br /> Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br /> Toll free phone: 8002490000<br /> E-mail: npc.drug@sfda.gov.sa<br /> Website: www.sfda.gov.sa/npc<br /><br /> Other GCC States:<br />Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No data on acute toxicity of Menotrophin in humans is available, but the acute toxicity of<br />urinary gonadotrophin preparations in animal studies has been shown to be very low. Too<br />high a dosage of Menotrophin may lead to hyperstimulation of the ovaries (see section 4.4).</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Gonadotrophins.<br />ATC CODE: G03GA02<br />The active substance in MERIONAL HG is highly purified human menopausal<br />gonadotrophin.<br />The FSH activity in MERIONAL HG is obtained from urine of post-menopausal women; the<br />LH activity is obtained both from urine of post-menopausal women and urine of pregnant<br />women. The preparation is standardised to have a FSH/LH activity ratio of approximately 1.<br />In the ovaries, the FSH-component in HMG induces an increase in the number of growing<br />follicles and stimulates their development. FSH increases the production of oestradiol in the<br />granulosa cells by aromatising androgens that originate in the Theca cells under the influence<br />of the LH-component.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The biological effectiveness of Menotrophin is mainly due to its FSH content. The<br />pharmacokinetics of Menotrophin following intramuscular or subcutaneous administration</p><p>shows great inter-individual variability. According to data collected from the studies<br />performed with Menotrophin, after a single injection of 300 IU, the maximum serum level of<br />FSH is reached approximately 19 hours after intramuscular injection and 22 hours after<br />subcutaneous injection. FSH peak concentrations reached 6.5 &plusmn;2.1 IU/L with an AUC0-t of<br />438.0 &plusmn; 124.0 IUxh/L after i.m. administration. After sc administration, Cmax reached 7.5<br />&plusmn;2.8 IU/L with an AUC0-t of 485.0 &plusmn; 93.5 IUxh/L.<br />AUC and Cmax levels for LH resulted to be significantly lower in the s.c. group compared to<br />the i.m group. This result may be due to very low levels detected (close to or below the<br />detection limits) in both groups and to a great intra- and inter-individual variability.<br />After that, the serum level decreases by a half-life of approximately 45 hours following<br />intramuscular administration and 40 hours following subcutaneous administration.<br />Excretion of Menotrophin, following administration, is predominantly renal.<br />No pharmacokinetic studies were performed in patients with impaired hepatic or renal<br />function.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No non-clinical studies have been performed with MERIONAL HG</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Powder: lactose monohydrate<br />Solvent: 0.9 per cent sodium chloride solution</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this product must not be mixed with other medicinal<br />products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
After reconstitution, immediate use is recommended.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 25&deg;C. Keep the vial and the ampoule of solvent in the outer carton, in<br />order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1 set contains: Powder in a vial (type I glass), sealed with a rubber closure and held in place<br />with a flip-off cap (aluminium and coloured plastic: 75 IU light green, 150 IU dark green) +<br />1 ml of solvent in an ampoule (type I glass). Pack size of 1, 5 and 10 sets.<br />Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The solution must be prepared just before injection.<br />Each vial is for single use only. The medicinal product must be reconstituted under aseptic<br />conditions.<br />Merional HG must only be reconstituted with the solvent provided in the package.<br />A clean preparation area should be prepared and hands should first be washed before the<br />solution is reconstituted.<br />Set out all the following items on the clean surface:<br />- two cotton-wool alcohol swabs (not provided)<br />- one vial containing Merional HG powder<br />- one solvent in ampoule<br />- one syringe (not provided)<br />- one needle for preparing the injection (not provided)<br />- a fine bore needle for subcutaneous injection (not provided)</p><p>Reconstitution of the solution for injection<br />Open the solvent ampoule containing the clear liquid.<br />A coloured mark is indicated on the tip of the solvent ampoule:<br />At this mark the ampoule neck is specifically designed to break more easily. Gently tap the<br />top of the ampoule to dislodge any liquid which may remain in the tip. Firmly press the<br />ampoule above the neck and break it while levering up at the coloured mark. Carefully place<br />the opened ampoule onto the preparation area.<br />Withdraw the solvent:<br />Attach the reconstitution needle (long needle) to the syringe. With the syringe in one hand,<br />hold the previously opened solvent ampoule, place the needle into it and withdraw all the<br />solvent.<br />Place the syringe very carefully on the preparation area and avoid touching the needle.</p><p>Prepare the solution for injection:<br />1. Remove the aluminium capsule cover from the vial containing Merional HG<br />powder and disinfect the rubber area of the cap with a cotton-wool swab<br />moistened with alcohol<br />2. Take the syringe and slowly inject the solvent into the powder vial through the<br />rubber cap.<br />3. Gently roll the vial between the hands until the powder is completely dissolved,<br />taking care to avoid creating foam.<br />4. Once the powder is dissolved (which, in general, occurs immediately), slowly<br />draw the solution into the syringe.<br />When reconstituting more than 1 vial of Merional HG, draw back the reconstituted contents<br />of the first vial into the syringe and slowly inject into a second vial after repeating the step 1<br />to 4.<br />If multiple vials of powder are used, the amount of menotrophin contained in 1 ml of<br />reconstituted solution will be as follows:</p><p>Merional HG 75 IU powder and<br />solvent for solution for injection<br />Number<br />of vials<br />used<br />Total amount of<br />menotrophin in 1 ml of<br />solution<br />1 75 IU<br />2 150 IU<br />3 225 IU<br />4 300 IU<br />5 375 IU<br />6 450 IU</p><p>Merional HG 150 IU powder and<br />solvent for solution for injection<br />Number of<br />vials used<br />Total amount of<br />menotrophin in 1 ml of<br />solution<br />1 150 IU<br />2 300 IU<br />3 450 IU<br />The solution must be clear and colourless.<br />Dispose of all used items:<br />Any unused product or waste material should be disposed of in accordance with local<br />requirements (once the injection is ended, all the needles and empty syringes should be<br />disposed of in an appropriate container).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                IBSA Institut Biochimique S.A.
Via al Ponte 13
6903 Switzerland.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                23.02.2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>